Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1245912.RA9I4q7DfWBmUY_qRas6czw-bZ_LOaLXu5zW4Q3S3fC6A130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1245912.RA9I4q7DfWBmUY_qRas6czw-bZ_LOaLXu5zW4Q3S3fC6A130_assertion type Assertion NP1245912.RA9I4q7DfWBmUY_qRas6czw-bZ_LOaLXu5zW4Q3S3fC6A130_head.
- NP1245912.RA9I4q7DfWBmUY_qRas6czw-bZ_LOaLXu5zW4Q3S3fC6A130_assertion description "[Stratification according to molecular subtype revealed prognostic relevance for PER1, PER3, CRY2 and NFIL3 in the ER+/HER2- subgroup, CLOCK and NPAS2 in the ER-/HER2- subtype, and ARNTL2 in HER2+ breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1245912.RA9I4q7DfWBmUY_qRas6czw-bZ_LOaLXu5zW4Q3S3fC6A130_provenance.
- NP1245912.RA9I4q7DfWBmUY_qRas6czw-bZ_LOaLXu5zW4Q3S3fC6A130_assertion evidence source_evidence_literature NP1245912.RA9I4q7DfWBmUY_qRas6czw-bZ_LOaLXu5zW4Q3S3fC6A130_provenance.
- NP1245912.RA9I4q7DfWBmUY_qRas6czw-bZ_LOaLXu5zW4Q3S3fC6A130_assertion SIO_000772 25485508 NP1245912.RA9I4q7DfWBmUY_qRas6czw-bZ_LOaLXu5zW4Q3S3fC6A130_provenance.
- NP1245912.RA9I4q7DfWBmUY_qRas6czw-bZ_LOaLXu5zW4Q3S3fC6A130_assertion wasDerivedFrom befree-2016 NP1245912.RA9I4q7DfWBmUY_qRas6czw-bZ_LOaLXu5zW4Q3S3fC6A130_provenance.
- NP1245912.RA9I4q7DfWBmUY_qRas6czw-bZ_LOaLXu5zW4Q3S3fC6A130_assertion wasGeneratedBy ECO_0000203 NP1245912.RA9I4q7DfWBmUY_qRas6czw-bZ_LOaLXu5zW4Q3S3fC6A130_provenance.